AHB(SH:688639)2025-04-22 13:00Financial Performance - The company's revenue for Q1 2025 was ¥687,062,042.25, representing a 37.20% increase compared to ¥500,781,373.59 in the same period last year[3]. - Net profit attributable to shareholders decreased by 40.98% to ¥51,096,095.71 from ¥86,574,111.12 year-on-year[3]. - Basic earnings per share fell by 40.98% to ¥0.20 from ¥0.35 in the previous year[4]. - Total operating revenue for Q1 2025 reached ¥687,062,042.25, a 37.2% increase from ¥500,781,373.59 in Q1 2024[14]. - Net profit for Q1 2025 was ¥49,138,959.43, a decrease of 42.7% compared to ¥85,868,603.65 in Q1 2024[15]. - Operating profit for Q1 2025 was ¥55,201,014.43, down 42.7% from ¥96,233,364.51 in Q1 2024[15]. - The company's basic earnings per share for Q1 2025 were ¥0.20, down from ¥0.35 in Q1 2024[15]. Cash Flow and Liquidity - The net cash flow from operating activities was ¥15,721,084.27, a significant recovery from a negative cash flow of ¥103,415,745.55 in the previous year[3]. - Cash flow from operating activities for Q1 2025 was ¥15,721,084.27, a significant improvement from a negative cash flow of ¥103,415,745.55 in Q1 2024[18]. - Cash and cash equivalents at the end of Q1 2025 totaled ¥417,922,208.58, compared to ¥370,426,208.82 at the end of Q1 2024[19]. - The company's cash and cash equivalents decreased slightly to CNY 417,922,208.58 from CNY 422,640,063.71, a decline of about 1.6%[9]. Research and Development - Research and development expenses totaled ¥33,876,164.43, an increase of 18.93% from ¥28,484,280.20[4]. - Research and development expenses for Q1 2025 were ¥33,876,164.43, an increase from ¥28,484,280.20 in Q1 2024[14]. - The proportion of R&D expenses to revenue decreased by 0.76 percentage points to 4.93% from 5.69%[4]. Assets and Liabilities - Total assets increased by 3.28% to ¥5,152,827,773.21 from ¥4,989,404,883.19 at the end of the previous year[4]. - Total current assets increased to CNY 1,444,126,941.50 as of March 31, 2025, from CNY 1,351,747,095.09 at the end of 2024, representing a growth of approximately 6.8%[10]. - Accounts receivable rose to CNY 307,865,657.84, up from CNY 283,817,119.25, indicating an increase of approximately 8.5%[9]. - Inventory increased significantly to CNY 478,747,013.30 from CNY 406,916,559.49, reflecting a growth of around 17.6%[9]. - Total liabilities amounted to CNY 2,544,479,626.38, up from CNY 2,431,026,713.17, marking an increase of about 4.7%[11]. - Non-current assets totaled CNY 3,708,700,831.71, a slight increase from CNY 3,637,657,788.10, representing a growth of approximately 2%[10]. - The company's total assets reached CNY 5,152,827,773.21, compared to CNY 4,989,404,883.19, indicating an increase of about 3.3%[11]. - Short-term borrowings decreased to CNY 491,252,498.88 from CNY 681,980,849.44, a reduction of approximately 28%[11]. - The company's retained earnings rose to CNY 1,131,103,477.24 from CNY 1,080,007,381.53, reflecting an increase of about 4.7%[11]. - The total equity attributable to shareholders increased to CNY 2,616,576,699.35 from CNY 2,564,649,586.26, marking a growth of approximately 2%[11]. Operating Costs and Expenses - Total operating costs for Q1 2025 were ¥632,740,817.63, up 53.7% from ¥411,603,470.89 in Q1 2024[14]. - Sales expenses for Q1 2025 were ¥20,860,067.94, up from ¥10,871,898.78 in Q1 2024[14]. - The company reported a net cash outflow from investing activities of ¥94,539,462.70 in Q1 2025, compared to a net outflow of ¥198,325,026.45 in Q1 2024[19]. Shareholder Information - The company reported a total of 8,624 common shareholders at the end of the reporting period[7].